Loading clinical trials...
Loading clinical trials...
This study was designed to check the efficacy of a new oral medical drug treatment, namely Cabergoline, for the treatment of Cushing Disease due to pituitary adenoma. Background: Cabergoline is a Dop...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Seth Gordhandas Sunderdas Medical College
NCT04569591 · Cushing's Disease, Pituitary Adenoma
NCT03346954 · Cushing's Disease
NCT03111810 · Iatrogenic Cushing's Disease
NCT00612066 · Cushing's Disease
NCT00434148 · Cushing's Disease
Seth GSMC & KEM hospital
Mumbai, Maharashtra
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions